Sotera Health Announces Closing of $1.5 Billion Term Loan B and $750 Million Senior Secured Note Financings
CLEVELAND, May 30, 2024 (GLOBE NEWSWIRE) — Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global […]
Biogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a Rare, Genetic Form of ALS
SOD1-ALS is a devastating, uniformly fatal, and ultra-rare genetic form of ALS estimated to affect less than 1,000 people in […]
BurgerFi to Consider Strategic Alternatives
Designates David Heidecorn as successor to Ophir Sternberg as Chairman of the Board Enters retention agreements with executive leadership to […]
Favorable Oncocyte VitaGraft Kidney Study Results Published in the New England Journal of Medicine
Late-breaking presentation of data at American Transplant Congress on Monday, June 3 Data show potential to monitor for therapeutic efficacy […]
SAB Biotherapeutics Announces Departure of Chief Financial Officer
MIAMI, May 30, 2024 (GLOBE NEWSWIRE) — SAB Biotherapeutics (Nasdaq: SABS) (the “Company” or “SAB”), a clinical-stage biopharmaceutical company with […]
Pharming Group provides update on ongoing regulatory review of leniolisib for the treatment of APDS in the European Union
Leiden, the Netherlands, May 30, 2024: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces today an […]
Verrica Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in New York
WEST CHESTER, Pa., May 30, 2024 (GLOBE NEWSWIRE) — Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology […]
Dianthus Therapeutics to Participate in the Jefferies Global Healthcare Conference
NEW YORK and WALTHAM, Mass., May 30, 2024 (GLOBE NEWSWIRE) — Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company […]
HOOKIPA Pharma to Host Investor Call on HB-200 Data Presented at American Society of Clinical Oncology 2024 Annual Meeting
Company will present promising preliminary progression-free survival and overall survival data for patients with combined positive score (CPS) ≥20 Conference […]
LanzaTech Names Head of Investor Relations
CHICAGO, May 30, 2024 (GLOBE NEWSWIRE) — LanzaTech Global, Inc. (NASDAQ: LNZA) (“LanzaTech” or the “Company”), the carbon recycling company […]
